These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 17929258)
41. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039 [TBL] [Abstract][Full Text] [Related]
42. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis. Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M Breast J; 2008; 14(6):551-5. PubMed ID: 19000054 [TBL] [Abstract][Full Text] [Related]
43. Intra-operative imprint cytology for assessing the sentinel node in breast cancer: results of its routine use over 8 years. Contractor K; Gohel M; Al-Salami E; Kaur K; Aqel N; Nigar E; Burke M; Singhal H Eur J Surg Oncol; 2009 Jan; 35(1):16-20. PubMed ID: 18554859 [TBL] [Abstract][Full Text] [Related]
44. The identification and treatment of isolated tumor cells reflect disparities in the delivery of breast cancer care. Tan JT; Bagnell M; Morgan JW; Wong JH; Roy-Chowdhury S; Lum SS Am J Surg; 2009 Oct; 198(4):508-10. PubMed ID: 19800457 [TBL] [Abstract][Full Text] [Related]
45. Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes. Karam AK; Hsu M; Patil S; Stempel M; Traina TA; Ho AY; Cody HS; Port ER; Morrow M; Gemignani ML Ann Surg Oncol; 2009 Jul; 16(7):1952-8. PubMed ID: 19381724 [TBL] [Abstract][Full Text] [Related]
46. Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system. Unal B; Gur AS; Kayiran O; Johnson R; Ahrendt G; Bonaventura M; Soran A Int J Clin Pract; 2008 Nov; 62(11):1785-91. PubMed ID: 19143863 [TBL] [Abstract][Full Text] [Related]
47. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years. Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841 [TBL] [Abstract][Full Text] [Related]
48. The clinical significance of sentinel lymph node micrometastasis in breast cancer. Patani N; Mokbel K Breast Cancer Res Treat; 2009 Apr; 114(3):393-402. PubMed ID: 18425678 [TBL] [Abstract][Full Text] [Related]
49. Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. Flynn LW; Park J; Patil SM; Cody HS; Port ER J Am Coll Surg; 2008 Apr; 206(4):616-21. PubMed ID: 18387465 [TBL] [Abstract][Full Text] [Related]
50. Histopathological work-up and interpretation of sentinel lymph nodes removed for vulvar squamous cell carcinoma. Regauer S Histopathology; 2009 Aug; 55(2):174-81. PubMed ID: 19694824 [TBL] [Abstract][Full Text] [Related]
51. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study. Bulte CS; van der Heiden-van der Loo M; Hennipman A Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809 [TBL] [Abstract][Full Text] [Related]
52. Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes. Martin Martinez MD; Veys I; Majjaj S; Lespagnard L; Schobbens JC; Rouas G; Filippov V; Noterman D; Hertens D; Feoli F; Bourgeois P; Durbecq V; Larsimont D; Nogaret JM Eur J Surg Oncol; 2009 Apr; 35(4):387-92. PubMed ID: 18639429 [TBL] [Abstract][Full Text] [Related]
53. [Low invasion in sentinel lymph node according to the European Working Group In Breast Screening Pathology (EWGBSP) recommendations and non sentinel invasion risk in breast cancer]. Gauthier T; Fermeaux V; Mollard J; Aubard Y Gynecol Obstet Fertil; 2009 Jun; 37(6):481-7. PubMed ID: 19457697 [TBL] [Abstract][Full Text] [Related]
54. First three sentinel lymph nodes accurately stage the axilla in breast cancer. Kidd SA; Keto JL; Tran H; Fitzgerald TL Am Surg; 2009 Mar; 75(3):253-6. PubMed ID: 19350863 [TBL] [Abstract][Full Text] [Related]
55. Factors predicting the sentinel node metastases in T1 breast cancer tumor: an analysis of 1416 cases. Capdet J; Martel P; Charitansky H; Lim YK; Ferron G; Battle L; Landier A; Mery E; Zerdoub S; Roche H; Querleu D Eur J Surg Oncol; 2009 Dec; 35(12):1245-9. PubMed ID: 19574018 [TBL] [Abstract][Full Text] [Related]
57. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature. Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020 [TBL] [Abstract][Full Text] [Related]
58. [The sentinel lymph node biopsy. Evolution and convalidation of the technique]. Riccio PA; Marabini P; Seracchioli S; Mingolla GP; Pavanello PM; Andreini L; Nannini R; Severi S; Monti G; Ferrari G Ann Ital Chir; 2007; 78(5):413-7; discussion 417-8. PubMed ID: 18338550 [TBL] [Abstract][Full Text] [Related]
59. Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases. Rutgers EJ J Clin Oncol; 2008 Feb; 26(5):698-702. PubMed ID: 18258976 [TBL] [Abstract][Full Text] [Related]
60. Interpretive disparity among pathologists in breast sentinel lymph node evaluation. Roberts CA; Beitsch PD; Litz CE; Hilton DS; Ewing GE; Clifford E; Taylor W; Hapke MR; Babaian A; Khalid I; Hall JD; Lindberg G; Molberg K; Saboorian H Am J Surg; 2003 Oct; 186(4):324-9. PubMed ID: 14553843 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]